The Manufacturers Life Insurance Company Takes $367,000 Position in Aveanna Healthcare Holdings Inc. $AVAH

The Manufacturers Life Insurance Company acquired a new stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 42,838 shares of the company’s stock, valued at approximately $367,000.

Several other hedge funds have also added to or reduced their stakes in the business. Dynamic Technology Lab Private Ltd grew its position in shares of Aveanna Healthcare by 8.9% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after buying an additional 1,151 shares during the last quarter. Barclays PLC raised its position in shares of Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after acquiring an additional 1,366 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of Aveanna Healthcare by 4.5% in the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after acquiring an additional 1,528 shares during the period. Intech Investment Management LLC lifted its stake in shares of Aveanna Healthcare by 9.8% in the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock worth $159,000 after acquiring an additional 1,739 shares during the period. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after acquiring an additional 2,400 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Aveanna Healthcare

In related news, major shareholder Paul Vigano sold 14,500,002 shares of the company’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $166,750,023.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Robert Williams, Jr. sold 14,500,002 shares of Aveanna Healthcare stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $166,750,023.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 59,904,505 shares of company stock valued at $649,301,514 over the last 90 days. Insiders own 5.30% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on AVAH. BMO Capital Markets increased their target price on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Royal Bank Of Canada upped their price objective on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research note on Monday, August 24th. Raymond James Financial increased their price objective on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. Truist Financial lifted their target price on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday, August 24th. Finally, UBS Group boosted their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $13.50.

Aveanna Healthcare Stock Performance

NASDAQ AVAH opened at $13.58 on Tuesday. The company has a market cap of $2.96 billion, a P/E ratio of 11.04, a PEG ratio of 0.85 and a beta of 1.97. The company has a fifty day simple moving average of $10.79 and a 200 day simple moving average of $8.35. Aveanna Healthcare Holdings Inc. has a 12-month low of $5.93 and a 12-month high of $14.00. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. The company had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. Sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 earnings per share for the current fiscal year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.